Comparative effects of scopolamine and quinpirole on the striatal fos expression induced by stimulation of D1 dopamine receptors in the rat

Brain Research

Volumn 893, Issue 1-2, 2001, Pages 202-214

  Wirtshafter, David ^a   Asin, Karen E ^b  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b ABBOTT LABORATORIES   (United States)

Author keywords

A 77636; Acetylcholine; c fos; Dopamine; Immediate early genes; Muscarinic receptors; Quinpirole; Scopolamine; Striosomes

Indexed keywords

3 (1 ADAMANTYL) 1 AMINOMETHYL 3,4 DIHYDRO 5,6 DIHYDROXY 1H 2 BENZOPYRAN; DOPAMINE 1 RECEPTOR; DOPAMINE 1 RECEPTOR STIMULATING AGENT; DOPAMINE 2 RECEPTOR STIMULATING AGENT; MUSCARINIC RECEPTOR BLOCKING AGENT; PROTEIN FOS; QUINPIROLE; SCOPOLAMINE BROMIDE; SCOPOLAMINE METHYL BROMIDE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; CHOLINERGIC NERVE CELL; CONTROLLED STUDY; CORPUS STRIATUM; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; DRUG MEGADOSE; DRUG POTENTIATION; DRUG RECEPTOR BINDING; IMMUNOREACTIVITY; MALE; NERVE CELL INHIBITION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; STAINING; STIMULATION; TREATMENT OUTCOME;

ADAMANTANE; ANIMALS; BENZOPYRANS; CORPUS STRIATUM; DOPAMINE AGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; IMMUNOHISTOCHEMISTRY; MALE; MUSCARINIC ANTAGONISTS; PROTO-ONCOGENE PROTEINS C-FOS; QUINPIROLE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE D1; SCOPOLAMINE;

EID: 0035794021     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(00)03315-1     Document Type: Article

References (76)

1. A within-subjects microdialysis/behavioral study of the role of striatal acetylcholine in D1-dependent turning
2. 1 receptor stimulated release of acetylcholine in rat striatum is mediated indirectly by activation of striatal neurokinin-1 receptors
3. Dopamine receptor agonists: Selectivity and dopamine receptor efficacy
4. 1 receptor agonists in mice and rats: Relation between behavioral effects and stimulation of adenylate cyclase activity in vitro
5. 1 receptor stimulation on rotation and c-fos expression
6. Amphetamine induces Fos-like immunoreactivity in the striatum of primates
7. 2 dopamine receptor stimulation on Fos-like immunoreactivity in the primate striatum
8. Medial to lateral gradient of neostriatal NGF receptors: Relationship to cholinergic neurons and NGF-like immunoreactivity
9. Localization of calcium binding proteins in the neostriatum
10. Fos immunoreactivity after stimulation or inhibition of muscarinic receptors indicates anatomical specificity for cholinergic control of striatal efferent neurons and cortical neurons in the rat
11. 2 dopamine regulation of acetylcholine release from striata of freely moving rats
12. 2-receptor regulation of striatal in vivo acetylcholine release
13. Characterization of cholinergic neurons in the rat neostriatum. A combination of choline acetyltransferase immunocytochemistry, Golgi impregnation and electron microscopy
14. Demonstration of a medial to lateral gradient in the density of cholinergic neuropil in the rat striatum
15. Striatal c-fos induction by cocaine or apomorphine occurs preferentially in output neurons projecting to the substantia nigra in the rat
16. 2 dopamine receptors and the regulation of striatal acetylcholine release in vivo
17. Muscarinic cholinergic receptor-mediated modulation on striatal c-fos mRNA expression induced by levodopa in rat brain
18. 1 receptor stimulation increases striatal acetylcholine release in the rat
19. The effect of intrastriatal application of directly and indirectly acting dopamine agonists and antagonists on the in vivo release of acetylcholine measured by brain microdialysis: The importance of the post-surgery interval
20. Modulatory functions of neurotransmitters in the striatum: Acetylcholine/dopamine/NMDA interactions
21. The us of c-fos as a metabolic marker in neuronal pathway tracing
22. +
23. Chemical signalling and striatal interneurons
24. Oxytocin neuron activation and Fos expression: A quantitative immunocytochemical analysis of the effect of lactation, parturition, osmotic and cardiovascular stimulation
25. The neostriatal mosaic: Multiple levels of compartmental organization
26. 1-containing neurons
27. Neurotransmitters and neuromodulators in the basal ganglia
28. Amphetamine and cocaine induce drug-specific activation of the c-fos gene in striosome-matrix and limbic subdivisions of the striatum
29. 1 and DARPP-32 gene expression in the rat striatum: An in situ hybridization study
30. 3H]hemicholinium-3
31. Differential response of striatal dopamine and muscarinic cholinergic receptor subtypes to the loss of dopamine. I. Effects of intranigral or intracerebroventricular 6-hydroxydopamine lesions of the mesostriatal dopamine system
32. Physiological, morphological and histochemical characterization of three classes of interneurons in rat neostriatum
33. A-77636: A potent and selective dopamine D1 receptor agonist with antiparkinsonian activity in marmosets
34. 2 synergism and receptor supersensitivity
35. Glutamate-dopamine balance in the striatum: Pre and post-synaptic interactions
36. The striatal cholinergic interneuron: Synaptic target of dopaminergic terminals?
37. 1 receptor-mediated effects on c-fos expression
38. 2 dopamine receptor gene expression by cholinergic neurons in the rat striatum
39. 1 DA receptor-mediated control of striatal acetylcholine release in vitro
40. 2 receptors in the rat striatal complex and its comparison with acetylcholinesterase
41. 1 dopamine receptor
42. L-Dopa stimulates c-fos expression in dopamine denervated striatum by combined activation of D-1 and D-2 receptors
43. 2 mediated responses
44. Differential effect of MK-801 and scopolamine on c-fos expression induced by L-DOPA in the striatum of 6-hydroxydopamine lesioned rats
45. 2 interaction
46. Ontogeny of M1 and M2 muscarinic binding sites in the striatum of the cat: Relationships to one another and to striatal compartmentalization
47. Projections of the pallidal complex: An autoradiographic study in the cat
48. Dopaminergic and muscarinic regulation of striatal enkephalin and substance P messenger RNA's following systemic and central administration of quinpirole and scopolamine
49. 1 dopamine receptor
50. Dye-coupling between rat striatal neurons recorded in vivo: Compartmental organization and modulation by dopamine
51. 2-like dopamine receptors synergistically activate rotation and c-fos expression in the dopamine-depleted striatum in a rat model of Parkinson's disease
52. Immunocytochemical localization of choline acetyltransferase within the rat neostriatum: A correlated light and electron microscopic study of cholinergic neurons and synapses
53. 2 receptor agonists on striatal acetylcholine release
54. Expression of the immediate early gene c-fos in basal ganglia: Induction by dopaminergic drugs
55. 1 -dopamine agonists selectively activate striatal c-fos independent of rotational behavior
56. 1 dopamine receptor activated c-fos
57. 2 dopamine receptors differentially regulate c-fos expression in striatonigral and striatopallidal neurons
58. The dopaminergic induction of Fos immunoreactivity in identified populations of globus pallidus neurons
59. 1 receptor selectivity and comparisons to the partial agonist SKF38393
60. Expression of c-fos protein in brain: Metabolic mapping at the cellular level
61. 1 and muscarinic receptors in the induction of striatal c-fos in rats depleted of dopamine as neonates
62. Central effects of anticholinergic drugs measured by the apomorphine gnawing test in mice
63. The central effects of a novel dopamine agonist
64. Topographic distribution of dopamine uptake, choline uptake, choline acetyltransferase and GABA uptake in the striata of weaver mutant mice
65. Monosynaptic cortical input and local axon collaterals of identified striatonigral neurons. A light and electron microscopic study using the Golgi-peroxidase transport-degeneration procedure
66. Intra-regional variations in the effect of aging on high affinity choline uptake, choline acetyltransferase and muscarinic cholinergic receptors in rat neostriatum
67. Are neostriatal dopamine receptors co-localized?
68. Co-stimulation of D1/D5 and D2 dopamine receptors leads to an increase in c-fos messenger RNA in cholinergic interneurons and a redistribution of c-fos messenger RNA in striatal projection neurons
69. 1 agonist SKF-82958 in the intact rat striatum
70. Intrastriatal injection of a muscarinic receptor agonist and antagonist regulates striatal neuropeptide mRNA expression in normal and amphetamine-treated rats
71. 2 dopamine receptors on Fos-like immunoreactivity in the normosensitive rat striatum
72. 1 agonist induced striatal c-fos expression in the rat
73. 1 dopamine agonist in intact rats
74. Effect of intrastriatal injections of atropine and methacholine on the apomorphine-induced gnawing in the rabbit
75. 1 dopamine receptors in striatum and not the frontal cortex